Doc, I did suggest that as a possibilty on the PRM thread and then admitted it may just be my wobbly nerves and that a deal is extremely close there if CJP and his few weeks can be relied upon.
As far as Oxb funding, I suppose we need to see the structure of any forthcoming deal. If it is small upfronts and more backended, we may have to part fund Trovax to what degree we can only guess at. Better than fully funding it though and in the meantime we have prosavin. I dont think they will need funding for another 2 years (gut feel).